Conversation between a clinical biologist and an artificial intelligence on prostate cancer biomarkers: a critical

Pierre-Jean Lamy1

  • 1Biopathalogie et génétique des cancers, imagenome, Inovie, Montpellier, France, Unité de recherche clinique, Clinique BeauSoeil, Montpellier, France.

PubMed